ATE132161T1 - Phosphopeptide - Google Patents

Phosphopeptide

Info

Publication number
ATE132161T1
ATE132161T1 AT87904015T AT87904015T ATE132161T1 AT E132161 T1 ATE132161 T1 AT E132161T1 AT 87904015 T AT87904015 T AT 87904015T AT 87904015 T AT87904015 T AT 87904015T AT E132161 T1 ATE132161 T1 AT E132161T1
Authority
AT
Austria
Prior art keywords
phosphopeptides
compositions
phosphohistidine
phosphothreonine
phosphopeptide
Prior art date
Application number
AT87904015T
Other languages
English (en)
Inventor
Eric Charles Reynolds
Original Assignee
Univ Melbourne
Victorian Dairy Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3771654&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE132161(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Melbourne, Victorian Dairy Ind filed Critical Univ Melbourne
Application granted granted Critical
Publication of ATE132161T1 publication Critical patent/ATE132161T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cereal-Derived Products (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Non-Alcoholic Beverages (AREA)
AT87904015T 1986-06-12 1987-06-12 Phosphopeptide ATE132161T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPH638586 1986-06-12

Publications (1)

Publication Number Publication Date
ATE132161T1 true ATE132161T1 (de) 1996-01-15

Family

ID=3771654

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87904015T ATE132161T1 (de) 1986-06-12 1987-06-12 Phosphopeptide

Country Status (12)

Country Link
EP (1) EP0268663B1 (de)
JP (1) JPH0776235B2 (de)
AT (1) ATE132161T1 (de)
BR (1) BR8707352A (de)
CA (1) CA1315480C (de)
DE (1) DE3751652T2 (de)
DK (1) DK173565B1 (de)
FI (1) FI92709C (de)
HU (1) HUT47309A (de)
NO (1) NO178665C (de)
NZ (1) NZ220673A (de)
WO (1) WO1987007615A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4606674A (en) * 1984-04-23 1986-08-19 Capron Mark E Structural wheel element
GB8811829D0 (en) * 1988-05-19 1988-06-22 Unilever Plc Oral compositions
GB8811830D0 (en) * 1988-05-19 1988-06-22 Unilever Plc Oral compositions
DK0391629T3 (da) * 1989-04-07 1997-12-15 Univ South Alabama Inhibering af mineralaflejring ved hjælp af phosphorylerede og beslægtede polyanioniske peptider
US5290685A (en) * 1990-02-22 1994-03-01 Meiji Milk Products Company Limited Method for separation and concentration of phosphopeptides
DE4007431A1 (de) * 1990-03-09 1991-09-12 Henkel Kgaa Den zahnschmelz schuetzende mund- und zahnpflegemittel
EP0523776A3 (en) * 1991-07-17 1993-05-26 Unilever N.V. Oral compositions containing a phosphopeptide
GB9117315D0 (en) * 1991-08-09 1991-09-25 Unilever Plc Method of controlling dental tartar and compositions for use therein
DK0651652T3 (da) * 1992-06-29 2000-07-24 Univ Melbourne Behandling af sensitive tænder
CA2181109A1 (en) * 1995-07-18 1997-01-19 Nobuko Imajo Polypeptide and process for measuring living body components using the same
US5837674A (en) 1996-07-03 1998-11-17 Big Bear Bio, Inc. Phosphopeptides and methods of treating bone diseases
AUPO566297A0 (en) 1997-03-13 1997-04-10 University Of Melbourne, The Calcium phosphopeptide complexes
AUPP051497A0 (en) * 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
CA2359647C (en) * 1999-03-25 2003-12-30 Warner-Lambert Company Oral care chewing gums and confections
US6846500B1 (en) * 1999-03-25 2005-01-25 Cadbury Adams Usa Llc Oral care chewing gums and method of use
AUPR517701A0 (en) 2001-05-21 2001-06-14 University Of Melbourne, The Dental restorative materials
AU2005306869B2 (en) 2004-11-16 2011-11-10 3M Innovative Properties Company Dental fillers including a phosphorus­containing surface treatment
CA2587278A1 (en) * 2004-11-16 2006-05-26 3M Innovative Properties Company Dental fillers, methods, compositions including a caseinate
AU2005306857A1 (en) 2004-11-16 2006-05-26 3M Innovative Properties Company Dental compositions with calcium phosphorus releasing glass
CN101098673B (zh) 2004-11-16 2012-02-29 3M创新有限公司 包括磷酸盐的牙科填料和组合物
WO2006056013A1 (en) * 2004-11-25 2006-06-01 The University Of Melbourne Stabilized calcium phosphate complexes
CA2611077C (en) 2005-06-07 2014-07-15 The University Of Melbourne Dental mineralization
PL1901702T3 (pl) * 2005-06-24 2015-07-31 Univ Melbourne Kompleksy jonowe
US20090130191A1 (en) 2005-10-27 2009-05-21 Sunstar Inc. Osteoclast Growth Inhibitor, Oral Composition, and Preventive or Therapeutic Agent for Bone Diseases, Containing Liposome-Encapsulated Lactoferrin
AU2007214265B2 (en) 2006-02-09 2012-06-14 The University Of Melbourne Fluoride composition and methods for dental mineralization
PL3024428T3 (pl) 2013-07-23 2021-07-05 The University Of Melbourne Kompozycje i sposoby mineralizacji zębów
RU2716134C2 (ru) 2013-12-24 2020-03-06 Де Юниверсити Оф Мельбурн Стабилизированные композиции на основе олова (II)
KR102862249B1 (ko) 2017-03-14 2025-09-19 더 유니버시티 오브 멜버른 치은염을 위한 치료
EA201991935A1 (ru) 2017-03-14 2020-02-14 Де Юниверсити Оф Мельбурн Комплексы для лечения чувствительности
CA3133097A1 (en) 2019-03-13 2020-09-17 The University Of Melbourne Compositions and methods for promoting mineralization

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU520417B2 (en) * 1977-09-07 1982-01-28 Sandoz Ltd Pentapeptides and derivatives
FR2474828B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
NZ199891A (en) * 1981-03-04 1985-07-31 Univ Melbourne Caries-inhibiting compositions containing casein or x-s-casein or phosuitin
US4463092A (en) * 1982-09-27 1984-07-31 Eli Lilly And Company Process for production antibiotic A53868
DE3320175A1 (de) * 1983-06-03 1984-12-06 Boehringer Mannheim Gmbh, 6800 Mannheim Aminosaeure- bzw. peptidderivate, verfahren zu deren herstellung und verwendung als arzneimittel

Also Published As

Publication number Publication date
CA1315480C (en) 1993-03-30
NO880589D0 (no) 1988-02-10
EP0268663A4 (de) 1990-04-10
DK70388D0 (da) 1988-02-11
BR8707352A (pt) 1988-09-13
DE3751652T2 (de) 1996-07-25
HUT47309A (en) 1989-02-28
NO178665C (no) 1996-05-08
FI92709C (fi) 1994-12-27
DE3751652D1 (en) 1996-02-08
JPH0776235B2 (ja) 1995-08-16
FI92709B (fi) 1994-09-15
NZ220673A (en) 1990-05-28
AU593365B2 (en) 1990-02-08
FI880629A0 (fi) 1988-02-11
NO178665B (no) 1996-01-29
DK173565B1 (da) 2001-03-19
EP0268663A1 (de) 1988-06-01
AU7548387A (en) 1988-01-11
EP0268663B1 (de) 1995-12-27
NO880589L (no) 1988-04-06
FI880629L (fi) 1988-02-11
WO1987007615A1 (en) 1987-12-17
DK70388A (da) 1988-04-11
JPS63503459A (ja) 1988-12-15

Similar Documents

Publication Publication Date Title
NO880589D0 (no) Fosfopeptider.
DE68924795D1 (de) Verfahren zur Radiomarkierung von Proteinen.
DK0792287T3 (da) Peptidanaloger af humant basisk myelinprotein
DE69000988D1 (de) Steuerungssystem fuer den motorzyklus.
DE69101760D1 (de) Mittel zur Verhinderung von Calcium enthaltenden Ablagerungen.
DE3687103D1 (de) Verfahren zur herstellung von n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline.
DE59300243D1 (de) Verfahren zur Herstellung von 3,5-Difluoranilin.
DE69004594D1 (de) Verfahren zur Verbrennung von Kohlenstaub.
ATE72963T1 (de) Konditionierfluessigkeiten von zahn- oder knochensubstanz.
DE3873243D1 (de) Ventilschaftabdichtungsbefestigung.
DE59408701D1 (de) Verfahren zur Herstellung von 2,3,4,5-Tetrafluor-benzotrifluorid
DE3761697D1 (de) Dichtung fuer ventile.
DE68910771D1 (de) Verfahren zur Herstellung von verbessertem Proteinhydrolysat.
DE69737476D1 (de) Neuer galaninrezeptor
DE59407675D1 (de) Verfahren zur Herstellung von 6H-Dibenz-(c,e)(1,2)-oxaphosphorin-6-on
DE69408085D1 (de) Verfahren zur Herstellung von 2,2-Diphenylhexafluorpropanen
DE69313832D1 (de) Verfahren zur Herstellung von 2,4-Dihydroxydiphenylsulfon
AR224003A1 (es) Compuestos herbicidas derivados de(2,6-dihaloisonicotinol)aminoacidos
DE69401368D1 (de) Verfahren zur Herstellung von 1,4-Dicyano-2-buten
ATE153344T1 (de) Hemmung von mineralabsetzung mit hilfe von phosphorylierten und ähnlichen polyanionischen peptiden
DE69010526D1 (de) Verfahren zur Herstellung von L-Alanin.
DE69202094D1 (de) Verfahren zur Herstellung von Verbindungen mit Aminoendgruppen.
FR2674253B1 (fr) Composition lyophilisee pour la multiplication de sequences d'acides nucleiques.
DE68922507D1 (de) Verfahren zur Herstellung von beta-2',2'-Difluornukleosiden.
ATE26109T1 (de) Acetylcystein-salze, ihre herstellung und verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time